Seasonal Allergic Rhinitis
Conditions
Interventions
Control Group:No Intervention
Sponsors
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for moderate-to-severe seasonal allergic rhinitis (SAR); (2) Have a documented SAR history of =2 years, with predictable seasonal onset and currently be in the remission phase; (3) Have a Total Nasal Symptom Score (TNSS) of =4 during the previous year's symptomatic period; (4) Be aged between 18 and 65 years; (5) Voluntarily agree to participate in this clinical study, be able to complete the required scale assessments as instructed, record the use of anti-allergic medications, and provide signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with comorbid upper respiratory diseases such as asthma or bronchitis; (2) Individuals with intolerance to moxa smoke; (3) Those experiencing fainting during moxibustion or strong aversion to moxibustion therapy; (4) Patients with other nasal conditions including chronic rhinitis, sinusitis, nasal polyps, or deviated nasal septum; (5) Individuals with psychiatric disorders, or who are pregnant or lactating; (6) Patients with severe comorbid conditions affecting the cardiovascular, cerebrovascular, hepatic, renal, or hematopoietic systems; (7) Those currently receiving Western medical treatments, traditional Chinese medicine therapies, or other complementary and alternative therapies for allergic rhinitis; (8) Subjects concurrently participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Attack Rate;Total Nasal Symptom Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total Non-Nasal Symptom Score;Rhinoconjunctivitis Quality of Life Questionnaire ;Rescue Medication Score ;serum IL-4, IL-5, IL-13 levels; Patient Satisfaction with Preventive Moxibustion;Patient Preference for Preventive Moxibustion;Incidence of Adverse Events; | — |
Countries
China
Contacts
Public ContactDu Shihao
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences
Outcome results
None listed